Published in BMJ on November 05, 2005
A comprehensive service. BMJ (2008) 1.00
Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles. Health Expect (2011) 0.90
Less than ideal: how oncologists practice with limited drug access. J Oncol Pract (2012) 0.79
Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer. Curr Oncol (2007) 0.75
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med (2001) 44.67
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol (2000) 8.08
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med (2001) 7.88
The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med (2004) 6.43
How the internet affects patients' experience of cancer: a qualitative study. BMJ (2004) 3.75
Informing and involving cancer patients in their own care. Lancet Oncol (2002) 2.95
Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA (2001) 2.55
Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Aff (Millwood) (2004) 1.63
Safety in numbers--monitoring risk in approved drugs. N Engl J Med (2005) 1.08
The impact of pharmacotherapy policy: a case study. Can J Clin Pharmacol (2001) 1.05
Use of complementary and alternative medicine in patients with cancer: a UK survey. Eur J Oncol Nurs (2005) 1.03
Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol (2001) 0.99
Health economics: can we afford an unrestricted use of new biological agents in gastrointestinal oncology? Curr Opin Oncol (2005) 0.89
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet (2004) 11.37
If I could just stop loving you: anti-love biotechnology and the ethics of a chemical breakup. Am J Bioeth (2013) 8.68
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol (2007) 6.82
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer (2006) 4.92
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol (2012) 4.91
Towards a global human embryonic stem cell bank. Am J Bioeth (2007) 3.98
Eligibility of overseas visitors and people of uncertain residential status for NHS treatment. BMJ (2004) 3.68
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
The medicalization of love. Camb Q Healthc Ethics (2014) 2.95
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol (2006) 2.59
Abortion: time to clarify Australia's confusing laws. Med J Aust (2004) 2.54
Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol (2008) 2.15
Getting moral enhancement right: the desirability of moral bioenhancement. Bioethics (2011) 2.13
Moral Enhancement, Freedom and the God Machine. Monist (2012) 2.04
Suicide in lung cancer: who is at risk? Chest (2013) 2.02
"You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet (2008) 1.87
Rational desires and the limitation of life-sustaining treatment. Bioethics (1994) 1.75
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening? J Clin Oncol (2007) 1.66
Science and law. Integrity in international stem cell research collaborations. Science (2006) 1.64
Consequentialism, reasons, value and justice. Bioethics (1998) 1.63
Is it better to be minimally conscious than vegetative? J Med Ethics (2012) 1.61
Propranolol reduces implicit negative racial bias. Psychopharmacology (Berl) (2012) 1.59
Synthetic biology and the ethics of knowledge. J Med Ethics (2010) 1.58
An international survey of predictive genetic testing in children for adult onset conditions. Genet Med (2005) 1.56
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res (2005) 1.52
The neuroethics of non-invasive brain stimulation. Curr Biol (2012) 1.51
Pregnant women with fetal abnormalities: the forgotten people in the abortion debate. Med J Aust (2008) 1.51
Sugaring the pill: ethics and uncertainties in the use of sucrose for newborn infants. Arch Pediatr Adolesc Med (2012) 1.45
Natural Selection, Childrearing, and the Ethics of Marriage (and Divorce): Building a Case for the Neuroenhancement of Human Relationships. Philos Technol (2012) 1.38
The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv (2009) 1.36
Desire for hastened death in patients with advanced disease and the evidence base of clinical guidelines: a systematic review. Palliat Med (2006) 1.33
Knowing when to stop: futility in the ICU. Curr Opin Anaesthesiol (2011) 1.30
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis (2013) 1.27
A simple solution to the puzzles of end of life? Voluntary palliated starvation. J Med Ethics (2013) 1.27
Survivorship issues following treatment completion--results from focus groups with Australian cancer survivors and health professionals. J Cancer Surviv (2008) 1.27
Addiction and autonomy: can addicted people consent to the prescription of their drug of addiction? Bioethics (2006) 1.24
The neural basis of intuitive and counterintuitive moral judgment. Soc Cogn Affect Neurosci (2011) 1.21
In favour of freezing eggs for non-medical reasons. Bioethics (2009) 1.20
A Liberal Account of Addiction. Philos Psychiatr Psychol (2010) 1.19
Development and pilot testing of a nurse-led posttreatment support package for bowel cancer survivors. Cancer Nurs (2011) 1.19
Increasing oncologists' skills in eliciting and responding to emotional cues: evaluation of a communication skills training program. Psychooncology (2008) 1.18
Lung cancer: challenges and solutions for supportive care intervention research. Palliat Support Care (2008) 1.15
To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. J Clin Oncol (2009) 1.12
Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer. Clin Cancer Res (2013) 1.10
Appropriate, timely referral to palliative care services: a name change will not help. J Clin Oncol (2013) 1.09
Improving survivorship care. J Clin Oncol (2012) 1.08
Should moral bioenhancement be compulsory? Reply to Vojin Rakic. J Med Ethics (2013) 1.08
Responding to desire to die statements from patients with advanced disease: recommendations for health professionals. Palliat Med (2006) 1.07
Brain damage and the moral significance of consciousness. J Med Philos (2009) 1.05
The relationship between unmet needs and distress amongst young people with cancer. Support Care Cancer (2011) 1.04
A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Support Care Cancer (2010) 1.03
Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol (2008) 1.02
From inside the bubble: migrants' perceptions of communication with the cancer team. Support Care Cancer (2010) 1.01
Carers, ethics and dementia: a survey and review of the literature. Int J Geriatr Psychiatry (2002) 1.00
Should we allow organ donation euthanasia? Alternatives for maximizing the number and quality of organs for transplantation. Bioethics (2010) 0.99
Time to re-evaluate gender segregation in athletics? Br J Sports Med (2010) 0.98
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging (2011) 0.97
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary. J Pathol (2013) 0.97
Liberal rationalism and medical decision-making. Bioethics (1997) 0.97
Importance of health literacy in oncology. Asia Pac J Clin Oncol (2012) 0.96
In vivo tracking of dendritic cells in patients with multiple myeloma. J Immunother (2008) 0.96
Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. Int J Gynecol Cancer (2012) 0.95
Pluripotent stem cell-derived gametes: truth and (potential) consequences. Cell Stem Cell (2009) 0.94
The Ashley Treatment: best interests, convenience, and parental decision-making. Hastings Cent Rep (2007) 0.93
An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma. Leuk Lymphoma (2007) 0.93
Human microbial challenge: the ultimate animal model. Lancet Infect Dis (2012) 0.93
Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance. Cancer Biol Ther (2005) 0.93
Beta adrenergic blockade reduces utilitarian judgement. Biol Psychol (2012) 0.92
"Holding your breath": interviews with young people who have undergone predictive genetic testing for Huntington disease. Am J Med Genet A (2007) 0.92
Does multidisciplinary care enhance the management of advanced breast cancer?: evaluation of advanced breast cancer multidisciplinary team meetings. J Oncol Pract (2010) 0.91
Thalassaemia major: the murky story of deferiprone. BMJ (2004) 0.91
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum. J Immunother (2009) 0.90
Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: a population-based study. Eur J Cancer (2013) 0.90
Desire-based and value-based normative reasons. Bioethics (1999) 0.90
Supportive and palliative care for lung cancer patients. J Thorac Dis (2013) 0.89
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer (2014) 0.89
A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myeloma. Clin Cancer Res (2005) 0.89
Clinician gate-keeping in clinical research is not ethically defensible: an analysis. J Med Ethics (2010) 0.89
'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option. Psychooncology (2014) 0.89
Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecol Oncol (2010) 0.88
Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype. Int J Gynecol Cancer (2013) 0.88
Spare embryos: 3000 reasons to rethink the significance of genetic relatedness. Reprod Biomed Online (2005) 0.88
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer. Expert Opin Investig Drugs (2005) 0.87
Early cardiovascular death in patients with cancer. N Engl J Med (2012) 0.86
Discussing complementary therapy use with early-stage breast cancer patients: exploring the communication gap. Integr Cancer Ther (2010) 0.86
Suboptimal health literacy in patients with lung cancer or head and neck cancer. Support Care Cancer (2013) 0.86
Cold or calculating? Reduced activity in the subgenual cingulate cortex reflects decreased emotional aversion to harming in counterintuitive utilitarian judgment. Cognition (2012) 0.86
A costly separation between withdrawing and withholding treatment in intensive care. Bioethics (2012) 0.86
Development and validation of a measurement tool to assess perceptions of palliative care. Psychooncology (2012) 0.85
Addiction is not an affliction: addictive desires are merely pleasure-oriented desires. Am J Bioeth (2007) 0.85
Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. Clin Colorectal Cancer (2006) 0.84
Improving patient emotional functioning and psychological morbidity: evaluation of a consultation skills training program for oncologists. Patient Educ Couns (2009) 0.84
Radiation with cisplatin or carboplatin for locally advanced cervix cancer: the experience of a tertiary cancer centre. J Med Imaging Radiat Oncol (2012) 0.84
The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer (2009) 0.84